Safety of high-dose inhaled corticosteroids

Respiratory Medicine

Volumn 87, Issue , 1993, Pages 27-31

  Barnes, N C ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE 17 PROPIONATE; BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; UNCLASSIFIED DRUG;

ADRENAL CORTEX FUNCTION; AGED; ASTHMA; BONE DENSITY; BONE TURNOVER; BRONCHUS MUCOSA; CATARACTOGENESIS; CHILD; CHILD GROWTH; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; GROWTH INHIBITION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LONG TERM CARE; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SIDE EFFECT; SKIN MANIFESTATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX; ADRENAL CORTEX HORMONES; ASTHMA; BONE AND BONES; GROWTH; HUMAN;

EID: 0027414148     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(05)80254-9     Document Type: Article

References (27)

1. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma
2. High dose beclomethasone inhaler in the treatment of asthma
3. Airway hyperresponsiveness and inflammation
4. Mucosal inflammation in asthma. State of the art
5. Guidelines for the management of asthma in adults: 1—chronic persistent asthma
6. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for chronic severe asthma
7. A study of the mechanism of the anti-asthmatic action of inhaled budesonide
8. Deposition of pressurised aerosols in the human respiratory tract
9. Improvement of pressurised aerosol/deposition with Nebuhaler spacer device
10. Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17α, 21-dipropionate in human liver and lung homogenate
11. Activation of beclomethasone dipropionate by hydrolysis to beclomethasone 17 monopropionate
12. Activation of beclomethasone dipropionate in bronchial secretion, and receptor affinities and solubility of inhalationally administeredglucocorticoids
13. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate and prednisolone in man
14. Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment ofchronic asthma
15. Comparison of a new corticosteroid aerosol, budesonide with beclomethasone dipropionate in the treatment of asthma
16. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 mcg/day) and budesonide (1600 mcg/day) for chronicasthma
17. Growth and childhood asthma
18. Growth of asthmatic children during treatment with budesonide: a double-blind trial
19. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler
20. Beclomethasone inhalation decreases serum osteocalcin concentrations
21. Bone turnover during high-dose inhaled corticosteroid treatment
22. Growth of asthmatic children
23. Effects of inhaled corticosteroids on hypothalamic pituitary deferred function and growth in children
24. Steroid aerosols and cataract formation
25. Purpura and dermal thinning associated with high dose inhaled corticosteroids
26. Easy bruising as a side effect of inhaled corticosteroids